Skip to main content

Table 1 Published studies on colorectal lymphoma

From: Primary lymphoma of the colon: report of two cases and review of literature

Author (year) [Ref.] Number of cases Histological type (WHO) Treatment modality Survival
Bairey et al. 2006 [3] 17 Diffuse large B cell lymphoma Multimodality, 9
Chemotherapy, 6
Surgery, 2
Median, 44 months
Musallam et al. 2010 [26] 9 Diffuse large B cell lymphoma, 6
Burkitt lymphoma, 3
Multimodality, 5
Chemotherapy, 3
Surgery, 1
Median, 25 months
Wong and Eu 2006 [11] 14 Diffuse large B cell lymphoma Multimodality, 11
Surgery, 3
5-year overall survival, 57%
Kim et al. 2005 [27] 95 B cell, 82.1%
T cell, 17.9%
Multimodality, 57
Chemotherapy, 23
Surgery, 15
5-year overall survival, 55.2%
Pandey et al. 2002 [28] 8 Large cell, 3
Small cell, 1
Mix large and small, 3
Lymphoblastic, 1
Surgery with adjuvant therapy in all 66% 4 years
Auger et al. 1990 [29] 22 Diffuse histiocytic lymphoma Multimodality, 14
Surgery, 8
N/A
Zighelboim and Larson 1994 [30] 15   Multimodality, 3
Chemotherapy, 12
5-year survival, 27%
Gonzalez et al. 2008 [5] 15   Multimodality, 12
Surgery, 3
Median survival, 60 months
Doolabh et al. 2000 [2] 7 Small non-cleaved, 5
Large cell, 2
Multimodality, 6
Surgery, 1
N/A
Cho et al. 1997 [31] 23   Multimodality, 14
Chemotherapy, 4
Surgery, 3
10-year survival, 61%
Fan et al. 2000 [10] 37 High grade, 29
Intermediate and low grade, 8
Multimodality, 22
Chemotherapy, 2
Surgery, 13
Median survival, 24 months
Stanojevic et al. 2008 [14] 24   Multimodality, 20
Surgery, 4
Median survival, 41.9%
Busch et al. 1994 [32] 19   Multimodality, 14
Chemotherapy, 4
Surgery, 1
Median survival, 45 months
Zinzani et al. 1997 [1] 32 High grade, 26
Low grade, 6
Multimodality, 22
Chemotherapy, 10
5-year overall survival, 59%
Zhou et al. 2011 [25] 32 B cell, 22 (DLBCL most common)
T cell, 10
B cell, multimodality (22)
T cell, surgery (8)
B cell DFS at 55 months, 88.2%
T cell, 3 alive after 23 months
She et al. 2011 [33] 10 B cell, 8
Burkitt, 1
Mantle cell, 1
Surgery, 7
Chemotherapy, 3
Median survival
Surgery, 17 months
Chemotherapy, 13 months
Zhai et al. 2012 [22] 46 B cell origin, 35
T cell, 11
  5-year survival, 64.2%
Progression-free survival, 49.3%
Pascual et al. 2013 [34] 7 Diffuse large B cell lymphoma, 6
Follicular lymphoma, 1
Multimodality, 2
Chemotherapy, 2
Surgery, 3
N/A
Huang et al. 2013 [35] 52 Diffuse large B cell lymphoma, 64.4% Multimodality, 43
Chemotherapy, 9
5-year survival, 71%
Tevlin et al. 2015 [36] 11 Diffuse large B cell lymphoma Multimodality, 9
Chemotherapy,  1
Radiotherapy alone, 1
Median event-free survival, 10 months